ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      1.02%
      US Tech 100
      20,114.40
      -0.02%
      Dow Jones
      39,721.36
      1.09%
      Brent Oil
      85.175
      0.15%
      Bitcoin
      58,134.63
      0.65%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Iovance Biotherapeutics Inc (IOVA)

      7. Iovance Biotherapeutics Inc (IOVA) News

      IOVA

      Iovance Biotherapeutics (IOVA)

      Iovance Biotherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IOVA
      DateTimeSourceHeadlineSymbolCompany
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      03/04/20246:30AMGlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
      03/01/20245:00PMGlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
      02/29/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      02/28/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      02/28/20244:01PMGlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
      02/22/20244:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      02/22/20248:45AMGlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
      02/21/20244:44PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
      02/20/20245:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      02/20/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
      02/20/20246:30AMGlobeNewswire Inc.Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common StockNASDAQ:IOVAIovance Biotherapeutics Inc
      02/20/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      02/16/20245:30PMGlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
      02/16/20243:38PMGlobeNewswire Inc.Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
      02/16/20243:19PMGlobeNewswire Inc.Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
      02/14/20246:16AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IOVAIovance Biotherapeutics Inc
      01/19/20245:15PMGlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
      01/18/20246:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
      01/18/20246:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
      01/18/20246:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
      01/08/20245:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      12/28/20237:27AMIH Market NewsWall Street Highlights: Amazon to Introduce Ads on Prime Video, JD.com Raises Salaries in 2024, and MoreNASDAQ:IOVAIovance Biotherapeutics Inc
      12/27/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
      12/27/20237:54AMDow Jones NewsIovance Shares Fall Premarket As FDA Places Study On Hold After Patient DeathNASDAQ:IOVAIovance Biotherapeutics Inc
      12/27/20237:00AMGlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
      12/22/20235:15PMGlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
      11/17/20235:00PMGlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
      11/07/20235:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
      11/07/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:IOVA